JPI Healthcare

At a glance

JPI Healthcare filed 21 disclosures in the last 12 months, including 5 insider, 2 buyback and 1 earnings. The most recent key filing was on Aug 31.

Revenue for 2025 was ₩48.5B, up 7.6% on 2024. Operating margin was 10% against 8.7% a year earlier. Debt was 31% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩22.7B and operating profit of ₩2.6B.

The 2025 annual report lists 143 employees with an average tenure of 7.6 years and average pay of ₩56.7M, #1139 of 1,829 listed companies by average pay. Its 6 directors and auditors were paid ₩116M each on average. It paid ₩250 per common share in cash dividends, against ₩160 a year earlier (+56.3%). 김진국 and related parties held 37.61% at year end.

From the 2025 annual report

Staff: 143 (119 men, 24 women), of whom 2 on fixed-term contracts. Total pay for the year: ₩8.2B. Directors and auditors: 6, paid ₩695M in total.

Dividends (common shares)

Largest shareholder

김진국 holds 25.70%; with 3 related parties the group holds 37.61% of common shares at year end (from 50.51% at the start of the year).

Auditor: 삼덕회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary